DTP hepatitis B vaccine - Shantha Biotechnics

Drug Profile

DTP hepatitis B vaccine - Shantha Biotechnics

Alternative Names: Shantetra

Latest Information Update: 20 Sep 2005

Price : $50

At a glance

  • Originator Shantha Biotechnics
  • Class Hepatitis B vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Diphtheria; Hepatitis B; Pertussis; Tetanus

Most Recent Events

  • 12 Sep 2005 Launched for Diphtheria in India (IM)
  • 12 Sep 2005 Launched for Hepatitis B prevention in India (IM)
  • 12 Sep 2005 Launched for Pertussis in India (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top